Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 17, 2023
Abstract
Background:
During
the
past
three
years
of
COVID-19
pandemic,
has
been
recognized
to
cause
various
neurological
complications,
including
rare
posterior
reversible
encephalopathy
syndrome
(PRES).
However,
it
remains
controversial
whether
infection
with
severe
acute
respiratory
coronavirus
2
(SARS-CoV-2)
or
widely
coexisting
known
factors
PRES
such
as
hypertension,
kidney
injury,
and
use
immunosuppressants
in
patients
play
main
role
pathogenesis
associated
COVID-19.
Case
presentation:
Here
we
report
a
case
an
18-year-old
female
mild
SARS-CoV-2
who
had
no
related
PRES.
We
also
conducted
literature
search
using
PubMed
for
similar
cases
summarized
clinical
characteristics
these
patients.
Conclusions:
These
strongly
suggest
that
among
numerous
may
trigger
COVID-19,
itself
be
one
core
factors.
GeroScience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 7, 2025
Abstract
Long
COVID
(also
known
as
post-acute
sequelae
of
SARS-CoV-2
infection
[PASC]
or
post-COVID
syndrome)
is
characterized
by
persistent
symptoms
that
extend
beyond
the
acute
phase
infection,
affecting
approximately
10%
to
over
30%
those
infected.
It
presents
a
significant
clinical
challenge,
notably
due
pronounced
neurocognitive
such
brain
fog.
The
mechanisms
underlying
these
effects
are
multifactorial,
with
mounting
evidence
pointing
central
role
cerebromicrovascular
dysfunction.
This
review
investigates
key
pathophysiological
contributing
cerebrovascular
dysfunction
in
long
and
their
impacts
on
health.
We
discuss
how
endothelial
tropism
direct
vascular
trigger
dysfunction,
impaired
neurovascular
coupling,
blood–brain
barrier
disruption,
resulting
compromised
cerebral
perfusion.
Furthermore,
appears
induce
mitochondrial
enhancing
oxidative
stress
inflammation
within
cells.
Autoantibody
formation
following
also
potentially
exacerbates
injury,
chronic
ongoing
compromise.
These
factors
collectively
contribute
emergence
white
matter
hyperintensities,
promote
amyloid
pathology,
may
accelerate
neurodegenerative
processes,
including
Alzheimer’s
disease.
emphasizes
critical
advanced
imaging
techniques
assessing
health
need
for
targeted
interventions
address
complications.
A
deeper
understanding
essential
advance
treatments
mitigate
its
long-term
consequences.
Journal of Internal Medicine,
Journal Year:
2023,
Volume and Issue:
294(5), P. 563 - 581
Published: Sept. 27, 2023
Abstract
The
long‐term
effects
of
COVID‐19
on
cognitive
function
have
become
an
area
increasing
concern.
This
paper
provides
overview
characteristics,
risk
factors,
possible
mechanisms,
and
management
strategies
for
dysfunction
in
post‐COVID‐19
condition
(PCC).
Prolonged
is
one
the
most
common
impairments
PCC,
affecting
between
17%
28%
individuals
more
than
12
weeks
after
infection
persisting
some
cases
several
years.
Cognitive
dysfunctions
can
be
manifested
as
a
wide
range
symptoms
including
memory
impairment,
attention
deficit,
executive
dysfunction,
reduced
processing
speed.
Risk
factors
developing
with
or
without
impairments,
include
advanced
age,
preexisting
medical
conditions,
severity
acute
illness.
underlying
mechanisms
remain
unclear,
but
proposed
contributors
neuroinflammation,
hypoxia,
vascular
damage,
latent
virus
reactivation
not
excluding
possibility
direct
viral
invasion
central
nervous
system,
illustrating
complex
pathology.
As
individual
variation
large,
neuropsychological
examination
person‐centered
multidimensional
approach
are
required.
According
to
World
Health
Organization,
limited
evidence
COVID‐19‐related
necessitates
implementing
rehabilitation
interventions
from
established
practices
similar
conditions.
Psychoeducation
compensatory
skills
training
recommended.
Assistive
products
environmental
modifications
adapted
needs
might
helpful.
In
specific
attention‐
working
dysfunctions,
training—carefully
monitored
intensity—might
effective
people
who
do
suffer
post‐exertional
malaise.
Further
research
crucial
evidence‐based
impairments.
Current Opinion in Neurology,
Journal Year:
2023,
Volume and Issue:
unknown
Published: April 5, 2023
Purpose
of
review
This
is
an
expert
overview
on
recent
literature
about
the
complex
relationship
between
coronavirus
disease
2019
(COVID-19)
and
headache.
Recent
findings
Long
COVID
a
clinical
syndrome
characterized
by
presence
persistent
symptoms
following
severe
acute
respiratory
2
(SARS-CoV-2)
infection.
Headache
one
most
common
described
often
as
throbbing
pain,
associated
with
photo
phonofobia
worsening
physical
exercise.
In
COVID-19,
headache
usually
moderate
or
severe,
diffuse
oppressive
although
sometimes
it
has
been
migraine-like
phenotype,
especially
in
patients
previous
history
migraine.
intensity
during
phase
seems
to
be
important
predictor
duration
over
time.
Some
COVID-19
cases
can
cerebrovascular
complications,
red
flags
secondary
headaches
(e.g.
new
unresponsive
headache,
onset
neurological
focal
signs)
should
urgently
investigated
imaging.
Treatment
goals
are
reduction
number
crises,
prevention
chronic
forms.
Summary
help
clinicians
approach
infection
from
SARS-CoV-2,
particular
attention
long
COVID.
Zeitschrift für Neuropsychologie,
Journal Year:
2023,
Volume and Issue:
34(2), P. 57 - 70
Published: May 24, 2023
Abstract:
Cognitive
sequelae
after
recovery
from
an
initial
COVID-19
disease
are
present
in
a
subset
of
affected
individuals,
coalescing
around
several
important
issues
such
as
effects
age,
severity,
comorbidities,
and
other
factors.
Some
neuropsychological
symptoms
appear
more
common
among
certain
patient
populations.
Comorbidities
may
complicate
assessment
well.
Hence,
we
need
guideline-based
evaluation
to
guide
rehabilitation.
Drawing
the
recent
revision
German
National
Guideline
for
Long-
Post-COVID
Syndrome
current
advances
international
guidance
on
assessment,
this
article
provides
practical
scientifically
informed
recommendations
individuals
recovering
coronavirus-related
diseases.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2022,
Volume and Issue:
12
Published: Dec. 22, 2022
The
gut
microbiota
undergoes
significant
alterations
in
response
to
viral
infections,
particularly
the
novel
SARS-CoV-2.
As
impaired
can
trigger
numerous
neurological
disorders,
we
suggest
that
long-term
symptoms
of
COVID-19
may
be
related
intestinal
disorders
these
patients.
Thus,
have
gathered
available
information
on
how
virus
affect
gastrointestinal
systems,
both
acute
and
recovery
phase
disease,
described
several
mechanisms
through
which
this
dysbiosis
lead
such
as
Guillain-Barre
syndrome,
chronic
fatigue,
psychiatric
depression
anxiety,
even
neurodegenerative
diseases
Alzheimer’s
Parkinson’s
disease.
These
mediated
by
inflammatory
cytokines,
well
certain
chemicals
hormones
(e.g.,
CCK),
neurotransmitters
5-HT),
etc.
short-chain
fatty
acids),
autonomic
nervous
system.
In
addition
direct
influences
virus,
repurposed
medications
used
for
patients
also
play
a
role
dysbiosis.
conclusion,
although
there
are
many
dark
spots
our
current
knowledge
mechanism
COVID-19-related
gut-brain
axis
disturbance,
based
evidence,
hypothesize
two
phenomena
more
than
just
coincidence
highly
recommend
large-scale
epidemiologic
studies
future.
Heliyon,
Journal Year:
2023,
Volume and Issue:
9(5), P. e15644 - e15644
Published: April 20, 2023
Angiotensin
converting
enzyme
2
(ACE2)
is
a
homolog
of
ACE
(a
transmembrane
bound
dipeptidyl
peptidase
enzyme).
ACE2
converts
angiotensinogen
to
the
heptapeptide
angiotensin-(1–7).
and
its
product,
angiotensin-(1–7),
have
counteracting
effects
against
adverse
actions
other
members
renin-angiotensin
system
(RAS).
principal
were
considered
an
under
recognized
arm
RAS.
The
COVID-19
pandemic
brought
light
this
RAS
with
special
focus
on
ACE2.
Membrane
serves
as
receptor
for
SARS-CoV-2
viral
entry
through
spike
proteins.
Apart
from
that,
also
involved
in
pathogenesis
various
diseases
like
cardiovascular
disease,
cancer,
respiratory
diseases,
neurodegenerative
infertility.
present
review
focuses
molecular
mechanism
infertility
including
SARS-CoV-2.
This
summarizes
unveiled
roles
which
further
provides
intriguing
possibilities
use
activators
modulating
agents
diseases.
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(7), P. 2004 - 2004
Published: July 15, 2023
The
renin-angiotensin
system
(RAS)
is
one
of
the
biggest
challenges
cardiovascular
medicine.
significance
RAS
in
chronic
progression
SARS-CoV-2
infection
and
its
consequences
topics
that
are
currently
being
mostly
discussed.
undermines
balance
between
beneficial
harmful
pathways.
level
soluble
ACE2
membrane-bound
both
upregulated
by
endocytosis
SARS-CoV-2/ACE2
complex
tumor
necrosis
factor
(TNF)-α-converting
enzyme
(ADAM17)-induced
cleavage.
Through
link
processes
proliferation,
fibrous
remodelling
myocardium
initiated
from
acute
phase
disease,
continuing
into
long
COVID
stage.
In
term,
dysfunction
may
cause
an
impairment
effects
leading
to
thromboembolic
a
reduction
perfusion
target
organs.
main
aspects
ACE2-a
key
pathogenic
role
COVID-19
as
well
mechanisms
involvement
injuries
studied.
Therapeutic
directions
can
be
anticipated
relation
various
pathways
damage
patients
with
longCOVID
have
also
been
outlined.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(6), P. 1262 - 1262
Published: May 27, 2023
One
of
the
proposed
nutritional
therapies
to
support
drug
therapy
in
COVID-19
is
use
a
ketogenic
diet
(KD)
or
ketone
bodies.
In
this
review,
we
summarized
evidence
from
tissue,
animal,
and
human
models
looked
at
mechanisms
action
KD/ketone
bodies
against
COVID-19.
were
shown
be
effective
stage
virus
entry
into
host
cell.
The
β-hydroxybutyrate
(BHB),
by
preventing
metabolic
reprogramming
associated
with
infection
improving
mitochondrial
function,
reduced
glycolysis
CD4+
lymphocytes
improved
respiratory
chain
could
provide
an
alternative
carbon
source
for
oxidative
phosphorylation
(OXPHOS).
Through
multiple
mechanisms,
supported
immune
response.
animal
models,
KD
resulted
protection
weight
loss
hypoxemia,
faster
recovery,
lung
injury,
better
survival
young
mice.
humans,
increased
survival,
need
hospitalization
COVID-19,
showed
protective
role
abnormalities
after
It
appears
that
may
considered
as
clinical
intervention
assist
treatment
despite
fact
numerous
studies
indicate
SARS-CoV-2
alone
induce
ketoacidosis.
However,
such
requires
strong
scientific
validation.
Aging and Disease,
Journal Year:
2022,
Volume and Issue:
unknown, P. 0 - 0
Published: Jan. 1, 2022
Aging
is
characterized
by
persistent
low-grade
systematic
inflammation,
which
largely
responsible
for
the
occurrence
of
various
age-associated
diseases.
We
and
others
have
previously
reported
that
long-lived
people
(such
as
centenarians)
can
delay
onset
or
even
escape
certain
major
age-related
Here,
screening
blood
transcriptome
inflammatory
profiles,
we
found
individuals
had
a
relatively
lower
inflammation
level
(IL6,
TNFα),
accompanied
up-regulation
activating
transcription
factor
7
(ATF7).
Interestingly,
ATF7
expression
was
gradually
reduced
during
cellular
senescence.
Loss
induced
senescence,
while
overexpression
delayed
senescence
progress
senescence-associated
secretory
phenotype
(SASP)
secretion.
showed
anti-senescence
effects
were
achieved
inhibiting
nuclear
kappa
B
(NF-κB)
signaling
increasing
histone
H3K9
dimethylation
(H3K9me2).
In
Caenorhabditis
elegans,
significantly
suppressed
aging
biomarkers
extended
lifespan.
Our
findings
suggest
longevity-promoting
lowers
in
individuals.